The projects are developed from basic research to commercially viable projects that can be either spun out as separate companies, co-developed with external parties or out-licensed.
Toleranzia developing revolutionary tolerance-inducing treatments with the potential to cure autoimmune diseases. Read more
Alzinova develops innovative therapeutics for Alzheimer’s disease treatment. Read more